Live feed
Filing
SC 13D/A
SC 13D/A0000947871-24-000499·Enliven Therapeutics, Inc.
Schedule 13D ownership disclosure
Enliven Therapeutics Inc
Security class unavailable · CUSIP: 29337E102
Event date: 2024-05-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,918,163
- Percent of class
- 16.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000499
- Form type
- SC 13D/A
- Filer
- Enliven Therapeutics, Inc.
- CIK
- CIK 1672619
- Filed
- May 20, 2024
- Reporting period
- May 16, 2024
- Description
- Schedule 13D beneficial ownership